Alzamend Neuro, Inc. — Director's Dealing 2021

Jun 15, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-06-14

Reporting Person: Nisser Henry Carl (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options	$1.50	2024-04-30	Common Stock (1250000)		Direct

Footnotes

F1: Represents shares of the Issuer's Common Stock issuable upon the exercise of stock options (the "Options"), which are currently exercisable. Mr. Nisser was granted Options to purchase 1,250,000 shares of the Issuer's Common Stock, which Options vest ratably over four (4) years beginning on June 1, 2019. The Options are exercisable for a period of five (5) years at an exercise price of $1.50 per share. Of these Options, 677,083 shares of Common Stock are currently vested and exercisable.